Angiodynamics Inc's revenue was $320m in fiscal 2026, up 9.5% on the year before. Since fiscal 2010 ($216m) it has grown at a compound 2.5% a year. Over the last twelve months it was $325m.
Revenue history
US$ millions unless shown otherwise.
Fiscal years, plus the last twelve months (LTM) when newer.
Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.
Where the revenue comes from
Fiscal year to May 31, 2026
Med Device$170M
Med Tech$150M
Segments
Line of business
Revenue
Share
YoY
Med Device
$170M
53.2%
▲ 2.6%
Med Tech
$150M
46.8%
▲ 18.4%
Med Device$170M
Med Tech$150M
Products and services
Line of business
Revenue
Share
YoY
Med Device
$170M
53.2%
▲ 2.6%
Med Tech
$150M
46.8%
▲ 18.4%
United States$275M
Outside the US$45.3M
Geography
Region
Revenue
Share
YoY
United States
$275M
85.9%
▲ 9.5%
Outside the US
$45.3M
14.1%
▲ 9.0%
From Angiodynamics Inc's 10-K filed July 14, 2026, as tagged in the filing.
View filing. Indented rows are part of the
line above; their share is of that line. In the bars, the
faint bar behind is the year before.
Revenue against peers
Health Care Equipment: the closest covered companies by revenue. Last twelve months.
Figures from Angiodynamics Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026.
How we read and check them: methodology and data sources.
Not investment advice. Back to Angiodynamics Inc.